Veradermics is trading at $111.27, up +4.23% on September 21, 2026, amid a broad risk-on session.
- The S&P 500, Nasdaq Composite, and Dow Jones are higher, supported by falling oil prices, easing Treasury yields, and improving sentiment around U.S.-China talks.
- Recent analyst attention and anticipated Phase 3 data remain supportive background factors.
- No new company-specific announcement was identified for September 21.